I-Corps: Commercialization of Genetic Identification Services for Invasive Aquatic Plant Management
I-Corps:入侵性水生植物管理基因识别服务的商业化
基本信息
- 批准号:1338468
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-15 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Researchers have identified molecular genetic techniques to identify cryptic lineages of invasive aquatic plants - lineages that cannot be easily distinguished using traditional visual identification. These lineages frequently differ in traits that are relevant to their management, such as how they respond to herbicides. In particular, some lineages are herbicide resistant, which is an important emerging issue in aquatic ecosystem management.A major challenge for the successful and economically efficient management of invasive aquatic plant species is the ability to accurately determine which lineage(s) are present in a lake or pond before prescribing a specific management activity. For example, it is critical to distinguish invasive lineages from native species because native species are not typically permitted for management activities. Similarly, it is desirable to predict response to herbicides before they are applied, as herbicide failures have adverse economic and environmental effects. Thus, there is immediate need to translate basic research into commercial risk assessment tools that will provide knowledge-based management strategies for individual lakes.
研究人员已经确定了分子遗传技术来识别入侵水生植物的神秘谱系-使用传统的视觉识别无法轻易区分的谱系。这些谱系在与其管理相关的性状上经常不同,例如它们对除草剂的反应。如何准确地确定湖泊或池塘中的入侵水生植物种类,进而采取有效的管理措施,是当前水生植物管理面临的一个重要挑战。例如,区分入侵物种和本地物种是至关重要的,因为本地物种通常不允许用于管理活动。类似地,期望在除草剂施用之前预测对除草剂的响应,因为除草剂失效具有不利的经济和环境影响。因此,迫切需要将基础研究转化为商业风险评估工具,为各个湖泊提供以知识为基础的管理战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ryan Thum其他文献
Ryan Thum的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ryan Thum', 18)}}的其他基金
RUI: Evolutionary and ecological importance of hybridization and cryptic diversity in a rapidly expanding aquatic plant
RUI:快速扩张的水生植物中杂交和隐秘多样性的进化和生态重要性
- 批准号:
0918553 - 财政年份:2009
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
MRI: Acquisition of an automated genetic analyzer for interdisciplinary research and teaching at Grand Valley State University, an undergraduate institution
MRI:采购自动基因分析仪,用于本科院校大谷州立大学的跨学科研究和教学
- 批准号:
0922591 - 财政年份:2009
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
相似海外基金
SBIR Phase II: FlashPCB Service Commercialization and AI Component Package Identification
SBIR第二阶段:FlashPCB服务商业化和AI组件封装识别
- 批准号:
2335464 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Cooperative Agreement
ART: Technology, Entrepreneurship and Commercialization Hub (ART:TECH)
ART:技术、创业和商业化中心(ART:TECH)
- 批准号:
2331258 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Cooperative Agreement
Towards commercialization of GelDerm-a smart dressing for continuous wound monitoring
迈向 GelDerm 的商业化——一种用于连续伤口监测的智能敷料
- 批准号:
478262 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Operating Grants
Development and Commercialization of a Safe and Effective Mpox Subunit Vaccine with Global Impact
具有全球影响力的安全有效的 Mpox 亚单位疫苗的开发和商业化
- 批准号:
494292 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Operating Grants
Commercialization Readiness for Nerve Tape: a nerve repair coaptation aid
神经胶带的商业化准备:神经修复接合辅助工具
- 批准号:
10698977 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis
商业化准备试点 (CRP) 计划支持: 直接从样本鉴定心内膜炎常见病原体
- 批准号:
10758417 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
RADX Independent Test Assessment Program for MPOX Lesion Panel - Commercialization Center
MPOX 病变组的 RADX 独立测试评估计划 - 商业化中心
- 批准号:
10941137 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
PFI-TT: Commercialization of Low-Carbon Concrete Blocks at Scale
PFI-TT:低碳混凝土砌块的大规模商业化
- 批准号:
2234543 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
I-Corps: Commercialization of a Microscale Power Generator Driven by Bacterial Flagellar Motors
I-Corps:细菌鞭毛电机驱动的微型发电机的商业化
- 批准号:
2328593 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Development and Commercialization of a pupillometer to predict postoperative opioid-induced respiratory depression in children
用于预测儿童术后阿片类药物引起的呼吸抑制的瞳孔计的开发和商业化
- 批准号:
10838773 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别: